NASDAQ:LMAT

LeMaitre Vascular (LMAT) Stock Forecast, Price & News

$44.80

+1.27 (+2.92%)

(As of 05/20/2022 04:00 PM ET)

Add

Compare

Today's Range: $42.77
▼
$44.88
50-Day Range: $39.05
▼
$47.85
52-Week Range: $38.32
▼
$64.50

Volume: 93,024 shs
Average Volume: 180,850 shs
Market Capitalization: $983.36 million

P/E Ratio: 35.84
Dividend Yield: 1.15%
Beta: 1.29

30 days | 90 days | 365 days | Advanced Chart

Receive LMAT News and Ratings via Email

Sign-up to receive the latest news and ratings for LeMaitre Vascular and its competitors with MarketBeat's FREE daily newsletter.

About LeMaitre Vascular

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

May 21, 2022 | americanbankingnews.com

Zacks: Brokerages Anticipate LeMaitre Vascular, Inc. (NASDAQ:LMAT) Will Post Quarterly Sales of $41.26 Million

May 2, 2022 | americanbankingnews.com

Barrington Research Trims LeMaitre Vascular (NASDAQ:LMAT) Target Price to $50.00

May 2, 2022 | americanbankingnews.com

Q2 2022 Earnings Estimate for LeMaitre Vascular, Inc. Issued By Jefferies Financial Group (NASDAQ:LMAT)

April 30, 2022 | seekingalpha.com

LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q1 2022 Results - Earnings Call Transcript

April 30, 2022 | americanbankingnews.com

$42.18 Million in Sales Expected for LeMaitre Vascular, Inc. (NASDAQ:LMAT) This Quarter

April 30, 2022 | americanbankingnews.com

LeMaitre Vascular (NASDAQ:LMAT) Trading Down 7.4% Following Weak Earnings

April 28, 2022 | investing.com

Lemaitre Vascular Misses Q1 EPS by 1c

April 28, 2022 | finance.yahoo.com

LeMaitre Q1 2022 Financial Results

April 27, 2022 | markets.businessinsider.com

LeMaitre Vascular is about to announce its earnings — here's what to expect

April 22, 2022 | finance.yahoo.com

LeMaitre Vascular's (NASDAQ:LMAT) investors will be pleased with their favorable 68% return over the last three years

April 15, 2022 | finance.yahoo.com

LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022

April 10, 2022 | finance.yahoo.com

Is This Overlooked Stock a Buy After Its Dividend Hike?

March 27, 2022 | finance.yahoo.com

An Intrinsic Calculation For LeMaitre Vascular, Inc. (NASDAQ:LMAT) Suggests It's 24% Undervalued

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:LMAT
Previous Symbol
CUSIP: N/A
CIK: 1158895
Web: www.lemaitre.com
Phone: (781) 221-2266
Fax: 781-425-5049
Employees: 450
Year Founded: 1983

Sales & Book Value

Annual Sales: $154.42 million
Price / Sales: 6.37
Cash Flow: $1.79 per share
Price / Cash Flow: 25.03
Book Value: $11.74 per share
Price / Book: 3.82

Profitability

EPS (Most Recent Fiscal Year): $1.25
Net Income: $26.91 million
Net Margins: 17.09%
Pretax Margin: 22.00%
Return on Equity: 11.41%
Return on Assets: 9.64%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 7.74
Quick Ratio: 5.19

Price-To-Earnings

Trailing P/E Ratio: 35.84
Forward P/E Ratio: 35.84
P/E Growth: 3.47

Miscellaneous

Outstanding Shares: 21,950,000
Free Float: 19,208,000
Market Cap: $983.36 million
Optionable: Optionable

Company Calendar

Ex-Dividend for 3/24 Dividend: 3/07/2022
Dividend Payable: 3/24/2022
Last Earnings: 4/28/2022
Ex-Dividend for 6/2 Dividend: 5/16/2022
Today: 5/21/2022
Dividend Payable: 6/02/2022
Next Earnings (Estimated): 8/04/2022
Fiscal Year End: 12/31/2022

Social Links

MarketRank^™

Overall MarketRank^™

3.38 out of 5 stars

Medical Sector

2nd out of 1,416 stocks

Surgical & Medical Instruments Industry

1st out of 138 stocks

3.3 Analyst's Opinion

Consensus Rating
LeMaitre Vascular has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $59.33, LeMaitre Vascular has a forecasted upside of 32.4% from its current price of $44.80.
Amount of Analyst Coverage
LeMaitre Vascular has received no research coverage in the past 90 days.

4.8 Community Rank

Outperform Votes
LeMaitre Vascular has received 478 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
LeMaitre Vascular has received 183 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
LeMaitre Vascular has received 72.31% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about LeMaitre Vascular and other stocks. Vote “Outperform” if you believe LMAT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LMAT will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Yield
LeMaitre Vascular pays a meaningful dividend of 1.15%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
LeMaitre Vascular has been increasing its dividend for 11 years.
Dividend Coverage
The dividend payout ratio of LeMaitre Vascular is 40.00%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, LeMaitre Vascular will have a dividend payout ratio of 35.46% next year. This indicates that LeMaitre Vascular will be able to sustain or increase its dividend.

3.3 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LeMaitre Vascular insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $382,336.00 in company stock.
Percentage Held by Insiders
12.50% of the stock of LeMaitre Vascular is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
84.90% of the stock of LeMaitre Vascular is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for LeMaitre Vascular are expected to grow by 12.80% in the coming year, from $1.25 to $1.41 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of LeMaitre Vascular is 35.84, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 9.98.
Price to Earnings Ratio vs. Sector
The P/E ratio of LeMaitre Vascular is 35.84, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 12.54.
Price to Earnings Growth Ratio
LeMaitre Vascular has a PEG Ratio of 3.47. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
LeMaitre Vascular has a P/B Ratio of 3.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

LeMaitre Vascular (NASDAQ:LMAT) Frequently Asked Questions

Is LeMaitre Vascular a buy right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LeMaitre Vascular stock.
View analyst ratings for LeMaitre Vascular or view top-rated stocks.
When is LeMaitre Vascular's next earnings date?: LeMaitre Vascular is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for LeMaitre Vascular.
How were LeMaitre Vascular's earnings last quarter?: LeMaitre Vascular, Inc. (NASDAQ:LMAT) issued its quarterly earnings data on Thursday, April, 28th. The medical instruments supplier reported $0.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.28 by $0.01. The medical instruments supplier had revenue of $39.56 million for the quarter, compared to analyst estimates of $38.65 million. LeMaitre Vascular had a net margin of 17.09% and a trailing twelve-month return on equity of 11.41%. The firm's quarterly revenue was up 10.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.28 EPS.
View LeMaitre Vascular's earnings history.
How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?: LeMaitre Vascular announced a quarterly dividend on Tuesday, April 26th. Stockholders of record on Tuesday, May 17th will be given a dividend of $0.125 per share on Thursday, June 2nd. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.12%. The ex-dividend date of this dividend is Monday, May 16th.
View LeMaitre Vascular's dividend history.
Is LeMaitre Vascular a good dividend stock?: LeMaitre Vascular pays an annual dividend of $0.50 per share and currently has a dividend yield of 1.15%. LeMaitre Vascular has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of LeMaitre Vascular is 40.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, LeMaitre Vascular will have a dividend payout ratio of 35.46% next year. This indicates that LeMaitre Vascular will be able to sustain or increase its dividend.
View LeMaitre Vascular's dividend history.
What guidance has LeMaitre Vascular issued on next quarter's earnings?: LeMaitre Vascular updated its second quarter 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share (EPS) guidance of $0.29-$0.35 for the period, compared to the consensus EPS estimate of $0.39. The company issued revenue guidance of $40.10 million-$42.10 million, compared to the consensus revenue estimate of $42.61 million.
What price target have analysts set for LMAT?: 3 equities research analysts have issued twelve-month target prices for LeMaitre Vascular's shares. Their forecasts range from $50.00 to $70.00. On average, they anticipate LeMaitre Vascular's stock price to reach $59.33 in the next twelve months. This suggests a possible upside of 32.4% from the stock's current price.
View analysts' price targets for LeMaitre Vascular or view top-rated stocks among Wall Street analysts.
Who are LeMaitre Vascular's key executives?: LeMaitre Vascular's management team includes the following people:
Mr. George W. LeMaitre, Chairman & CEO (Age 57, Pay $882.03k)
Mr. David B. Roberts, Pres & Director (Age 58, Pay $603.01k) (LinkedIn Profile)
Mr. Joseph P. Pellegrino Jr., CFO, Treasurer, Sec. & Director (Age 57, Pay $518.6k) (LinkedIn Profile)
Mr. Trent G. Kamke, Sr. VP of Operations (Age 51, Pay $368.62k) (LinkedIn Profile)
Dr. George D. LeMaitre, Founder and Chairman of Scientific Advisory Board (Age 88)
Ms. Laurie A. Churchill, Sr. VP & Gen. Counsel (Age 51)
Ms. Kimberly L. Cieslak, VP of Marketing (Age 49)
Mr. Daniel J. Mumford, Director of HR (Age 40)
Mr. Andrew Hodgkinson, Sr. VP of Clinical, Regulatory & Quality Affairs (Age 46)
Mr. Stephane Maier, Sr. VP of EMEA Operations (Age 46)
What is George W. LeMaitre's approval rating as LeMaitre Vascular's CEO?: 13 employees have rated LeMaitre Vascular CEO George W. LeMaitre on Glassdoor.com. George W. LeMaitre has an approval rating of 33% among LeMaitre Vascular's employees. This puts George W. LeMaitre in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
Who are some of LeMaitre Vascular's key competitors?: Some companies that are related to LeMaitre Vascular include Merit Medical Systems (MMSI), Inari Medical (NARI), Haemonetics (HAE), NuVasive (NUVA), Axonics (AXNX), AtriCure (ATRC), Glaukos (GKOS), Beauty Health (SKIN), PROCEPT BioRobotics (PRCT), Embecta (EMBC), Nevro (NVRO), Paragon 28 (FNA), Atrion (ATRI), Silk Road Medical (SILK) and Antares Pharma (ATRS).
View all of LMAT's competitors.
What other stocks do shareholders of LeMaitre Vascular own?: Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include (CGC), AbbVie (ABBV), Sociedad Química y Minera de Chile (SQM), Gilead Sciences (GILD), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), NVIDIA (NVDA), Adobe (ADBE), Boeing (BA) and Salesforce (CRM).
What is LeMaitre Vascular's stock symbol?: LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."
Who are LeMaitre Vascular's major shareholders?: LeMaitre Vascular's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.47%), Conestoga Capital Advisors LLC (8.56%), Vanguard Group Inc. (6.50%), Copeland Capital Management LLC (5.54%), Geneva Capital Management LLC (3.95%) and State Street Corp (3.23%). Company insiders that own LeMaitre Vascular stock include David B Roberts, George W Lemaitre, George W Lemaitre, John A Roush, Joseph P Pellegrino Jr, Lawrence J Jasinski and Trent G Kamke.
View institutional ownership trends for LeMaitre Vascular.
Which major investors are selling LeMaitre Vascular stock?: LMAT stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, JPMorgan Chase & Co., Rice Hall James & Associates LLC, Aviva PLC, Geneva Capital Management LLC, Prudential Financial Inc., Principal Financial Group Inc., and Russell Investments Group Ltd.. Company insiders that have sold LeMaitre Vascular company stock in the last year include David B Roberts, John A Roush, Joseph P Pellegrino Jr, and Trent G Kamke.
View insider buying and selling activity for LeMaitre Vascular or view top insider-selling stocks.
Which major investors are buying LeMaitre Vascular stock?: LMAT stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., BlackRock Inc., Conestoga Capital Advisors LLC, Dimensional Fund Advisors LP, Grandeur Peak Global Advisors LLC, Copeland Capital Management LLC, Royce & Associates LP, and ProShare Advisors LLC.
View insider buying and selling activity for LeMaitre Vascular or or view top insider-buying stocks.
How do I buy shares of LeMaitre Vascular?: Shares of LMAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is LeMaitre Vascular's stock price today?: One share of LMAT stock can currently be purchased for approximately $44.80.
How much money does LeMaitre Vascular make?: LeMaitre Vascular has a market capitalization of $983.36 million and generates $154.42 million in revenue each year. The medical instruments supplier earns $26.91 million in net income (profit) each year or $1.25 on an earnings per share basis.
How many employees does LeMaitre Vascular have?: LeMaitre Vascular employs 450 workers across the globe.
Does LeMaitre Vascular have any subsidiaries?: The following companies are subsidiares of LeMaitre Vascular: Artegraft, Bio Nova Holdings Pty Ltd, Bio Nova International Pty Ltd, Biomateriali, CardioCel, Clinical Instruments, Credent, Endomed, Ideas for Medicine, Inavein, LeMaitre Acquisition LLC, LeMaitre Cardial SAS, LeMaitre Medical Technology (Shanghai) Co., LeMaitre Vascular, LeMaitre Vascular AS, LeMaitre Vascular GK, LeMaitre Vascular GmbH, LeMaitre Vascular Pty Ltd, LeMaitre Vascular S.r.l., LeMaitre Vascular SAS, LeMaitre Vascular Singapore Pte Ltd, LeMaitre Vascular Spain, LeMaitre Vascular Switzerland GmbH, LeMaitre Vascular ULC, LifeSpan, PeriVu, ProCol, Restore Flow Allografts, RestoreFlow, Syntel and Python, TRIVEX, Tru-Incise (Eze-Sit) OUS, Tru-Incise (Eze-Sit) US, UnBalloon, VCS Clip, VascuCel, Vascular Architects, Vascular Innovations, Vascutech Acquisition LLC, Vermed, Whittaker Screen Printing, XenoSure, and Xenotis Pty Ltd.
When was LeMaitre Vascular founded?: LeMaitre Vascular was founded in 1983.
What is LeMaitre Vascular's official website?: The official website for LeMaitre Vascular is www.lemaitre.com.
How can I contact LeMaitre Vascular?: LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at (781) 221-2266 or via fax at 781-425-5049.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

LeMaitre Vascular (LMAT) Stock Forecast, Price & News

About LeMaitre Vascular

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Company Calendar

Social Links

MarketRank™

Overall MarketRank™

3.3 Analyst's Opinion

4.8 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

4.2 Dividend Strength

3.3 Company Ownership

1.3 Earnings and Valuation

LeMaitre Vascular (NASDAQ:LMAT) Frequently Asked Questions

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

MarketRank^™

Overall MarketRank^™